CAPITAL COUNSEL LLC/NY

Position in ABBV — AbbVie Inc.

CIK 1114928 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$201,563

New position

Shares Held

801

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#3,951

of 4,153 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAPITAL COUNSEL LLC/NY holds $16,265,242 across 4 Drug Manufacturers - General names. ABBV ranks #4 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	68,928	$8,708,363
2	MRK	Merck & Co., Inc.	55,363	$7,114,145
3	AMGN	Amgen Inc	666	$241,171
4	ABBV	AbbVie Inc. This page	801	$201,563

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,563	801	—	Shares	Sole	2026-08-12
No filing history on record for this holder in this stock.